{"id":"bromebric-acid","rwe":[{"pmid":"6897357","year":"1982","title":"Evidence for the nonenzymatic and irreversible binding of cytembena to rat liver microsomes in vitro.","finding":"","journal":"Biochemical pharmacology","studyType":"Clinical Study"}],"tags":[{"label":"bromebric acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["sodium bromebrate","bromebric acid"],"offLabel":[],"synonyms":["sodium bromebrate","bromebric acid"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"bromebric acid","explanation":"Imagine your body's cells are like locks, and enzymes are like keys that unlock them. Bromebic acid is like a special key that blocks the enzyme from working properly, which can help treat certain conditions. However, the exact way it works is still a mystery.","oneSentence":"Bromebic acid is thought to work by inhibiting a specific enzyme or receptor, but the exact mechanism is unknown.","technicalDetail":"Bromebic acid is a small molecule that binds to a specific protein or enzyme, altering its activity and leading to a therapeutic effect. However, the precise binding site and molecular interactions are not well understood."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/400","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BROMEBRIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:03:34.518759","biosimilars":[],"competitors":[],"genericName":"bromebric acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"FGE8818GWA","CHEBI":"CHEBI:135179","INN_ID":"3063","UMLSCUI":"C0054091","ChEMBL_ID":"CHEMBL2106594","PUBCHEM_CID":"5358572","SECONDARY_CAS_RN":"21739-91-3","MESH_SUPPLEMENTAL_RECORD_UI":"C100245"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1982 Oct 15","pmid":"6897357","title":"Evidence for the nonenzymatic and irreversible binding of cytembena to rat liver microsomes in vitro.","journal":"Biochemical pharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"BROMEBRIC ACID","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bromebic acid is a small molecule drug of the bromebric acid class, but its details are limited. Its original developer and current owner are unknown. The target and approved indications of bromebic acid are also not specified. Its commercial status, including whether it is patented or generic, and key safety considerations are not available. Further research is needed to understand its pharmacological properties and clinical applications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}